• ExpertEd Brand Refresh 1150x135 Surgonc Podcast Banner
  • 19 SSO 014 Digital Banners MembershipBanner 1150x135 v5
  • SSO Mobile App Website Top 1150x135 Banner
  • 19 SSO 014 Digital Banners Landmark Series 1150x135 v5 1

ADVERTISEMENT

SurgOnc Today®

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.

Listen to the most recent episodes below or find all of the SurgOnc Today® episodes, organized by disease site, on ExpertEd@SSO. Make sure you don’t miss an episode by subscribing on Apple Podcasts, Spotify and Stitcher

2020 Practice Changing Trials in Sarcoma

Recent trials in sarcoma sought to determine the impact of neoadjuvant therapies and histologic/genomically specific treatments. Valerie Grignol, MD, Gabriel R. Tinoco Suarez, MD, and Alessandro Gronchi, MD, FSSO, discuss the following recent trials will. The EORTC-62902:STRASS trial evaluated the impact of neoadjuvant radiotherapy for retroperitoneal sarcoma on abdominal recurrence-free survival. A study by the Italian, Spanish, French and Polish Sarcoma groups sought to determine if histology-tailored neoadjuvant chemotherapy was superior to standard anthracycline plus ifosfamide for high-risk extremity and trunk soft tissue sarcoma for disease-free and overall survival. The NAVIGATOR study evaluated the PDGFRA inhibitor avapritinib and its activity in D842V-mutant gastrointestinal stromal tumors. Lastly the INVICTUS study evaluated the impact of further line therapy ripretinib, a switch-control tyrosine kinase inhibitor, on progression-free survival in advanced gastrointestinal stromal tumors.

Valerie Grignol, MD – Member, SSO Sarcoma Disease Site Work Group, Assistant Professor of Surgery, The Ohio State University

Gabriel R. Tinoco Suarez, MD – Medical Oncologist and Clinical Assistant Professor – Division of Medical Oncology at The Ohio State University

Alessandro Gronchi, MD, FSSO – Chair Sarcoma Service – Department of Surgery; Fondazione IRCCS Istituto Nazionale dei Tumori (Milan, Italy)

The Evolving Role of HIPEC in Ovarian Cancer

In this episode, Peritoneal Surface Malignancy Disease Site Workgroup Member, Beth Helmink, MD, PhD, from Washington University in St. Louis, reviews recent data regarding the evolving role of HIPEC in Ovarian Cancer.  Joining her for this discussion are two renowned gynecologic oncologists specializing the treatment of ovarian cancer– Willemien van Driel, MD, Netherlands Cancer Institute, and Ernst Lengyel, MD, PhD, University of Chicago.

Practice Changing Studies in Colorectal Surgical Oncology (2021)

In this episode, Karyn Stitzenberg, MD, MPH, Vice Chair of the SSO Colorectal Disease Site Work Group is joined by Patrick S. Sullivan, MD, FACS, FASCRS, Associate Professor of Surgery and Chief Quality Officer, Division of Colorectal Surgery at the Winship Cancer Institute of Emory University in Atlanta, Georgia. They review practice changing studies in colorectal surgical oncology from 2020.

Practice Changing Studies in Gastrointestinal Surgical Oncology (2021)

In this episode of SurgOnc Today™, Evan Glazer, MD, PhD, FACS, FSSO, Vice Chair of the SSO Gastrointestinal Disease Site Workgroup, is joined by Julie Hallet MD, MSc, FRCSC, Natalie Coburn MD, MPH and Jesse Zuckerman, MDCM, all from the University of Toronto. Focusing on 2020 Practice Changing Studies in Gastrointestinal Surgical Oncology, they review the Declining Use of Red Blood Cell Transfusions for Gastrointestinal Cancer Surgery: A Population-Based Analysis. Ann Surg Oncol 28, 29–38 (2021). https://doi.org/10.1245/s10434-020-09291-y

Practice Changing Studies in Hepato-Pancreato-Biliary Surgical Oncology (2021)

In this episode, Melissa Hogg, MD, from Northshore University Health System, chair of the Hepato-Pancreato-Biliary Disease Site Workgroup, is joined by Jashodeep Datta, MD, from the University of Miami School of Medicine in Miami, FL and Dr. Carrie Luu, MD, from Saint Louis University Hospital in St. Louis, MO. They review practice changing studies in Hepato-Pancreato-Biliary Surgical Oncology from 2020. They discuss the SWOG S1505 clinical trial manuscript and the Know Your Tumor Registry publication.

Use of Wire-Free Alternatives for Localization of Non-Palpable Breast Lesions for Surgery

In this episode, Ko Un “Clara” Park, MD, FACS, Member of the SSO Breast DSWG and Assistant Professor of Surgery at The Ohio State University Wexner Medical Center reviews wire-free alternatives for localization of non-palpable breast lesions for surgery. Panelists and alternatives reviewed include:

Dr. Michael Alvarado, Professor of Surgery and member of the breast care and melanoma programs at the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the use of radioactive seed.

Dr. Susan Hoover, Professor of Surgery at the Moffitt Cancer Center in Tampa, Florida, reviews other ‘seed-like’ localizers such as Savi Scout, Magseed, and the Faxitron localizer.

Dr. Lee G. Wilke, the Hendricks endowed chair in Breast Cancer Research; a tenured Professor of Surgery and the Associate Director for Clinical Research for the University of Wisconsin Carbone Cancer Center as well as the Director of the UW Health Breast Center in Madison, WI, discusses an innovative intraoperative navigation platform for tumor identification, a Smart Clip technology which can be inserted at time of the biopsy.

Genetic Evaluation and Management of the Patient with Primary Hyperparathyroidism Part 1

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC.

This episode is the first of a two-part series.  The expert panel will discuss the incidence, prevalence, and epidemiology of primary hyperparathyroidism (PHPT).  They will review inherited syndromes associated with PHPT as well as when to send patients/families to genetic counseling for further evaluation and how to diagnose those syndromes.  Part two of our series will focus on the surgical management of hereditary forms of PHPT.

Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

Genetic Evaluation and Management of the Patient with Primary Hyperparathyroidism Part 2

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC.

This podcast is the second of a two-part series.  Whereas the first episode discussed an overview of primary hyperparathyroidism (PHPT) and the inherited syndromes associated with it, this episode will focus on the surgical management of hereditary forms of PHPT, specifically multiple endocrine neoplasia syndromes types 1 & 2 (MEN1 & MEN2).

Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

ACS Commission on Cancer Surgery Standards

 


In this episode, SSO Immediate Past President James Howe, MD, SSO Secretary Kelly Hunt, MD, and Matthew Katz, MD, discuss ACS Commission on Cancer accreditation standards 5.3 through 5.8, what these standards are, where they came from, and why they are so important to all surgeons and their patients.

Timothy Mullett, MD, Stephen Swisher, MD, and Nirmal Veeramachaneni, MD discuss the Commission on Cancer (CoC) Standard 5.8 including a review of the requirements for nodal assessment during curative operation for lung cancer and best practices to accomplish the requirement.

The 2020 Commission on Cancer (CoC) accreditation standards introduced six new operative standards pertaining to the technical aspects of cancer surgery. In this episode, SSO Colorectal Disease Site Work Group Chair, David Shibata, MD, James Fleshman, MD, and David Dietz, MD, describe Standard 5.7, Total Mesorectal Excision (TME) for Rectal Cancer and will cover the details of the standard, the key steps of TME, and its’ supporting evidence.

In this episode of SurgOnc Today®, Richard White, MD, Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Nasreen Vohra, MD reviews updates on local therapies and Michael Lowe, MD, MA, reviews updates on neoadjuvant trials in melanoma.

In this episode, Edward Levine, MD Chair of the SSO Peritoneal Surface Malignancy DSWG, is joined by Brian Badgwell, MD of MD Anderson Cancer Center and Pieter Tanis, MD, PhD of the University of Amsterdam.  They discuss whether patients at high risk of peritoneal dissemination from gastric and colon cancers should undergo HIPEC as an adjuvant therapy. 

Unplanned surgical excisions of soft tissue sarcomas (“whoops operations”) can complicate the subsequent multidisciplinary management of the primary tumor due to potential microscopic tumor seeding of prior surgical sites, violation of uninvolved anatomic compartments, and sometimes a lack of gross residual tumor on staging imaging. Valerie Grignol, MD and Kilian Salerno, MD join John M. Kane III, MD, Vice-Chair of the SSO Sarcoma Disease Site Work Group, to discuss how unplanned excisions might alter the surgical and radiation decision-making for the treatment of soft tissue sarcomas.

In part two of the HPB Incidentalomas episode, Alexander A. Parikh, MD, Vice Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD discuss the incidence, workup, treatment options, and controversies in the management of benign and indolent incidental lesions involving the duodenum and pancreas.

In this episode of SurgOnc Today®, Sean Dineen, MD, Laura Lambert, MD, and Chukwuemeka Ihemelandu, MD, discuss the state of the art management of colorectal cancer metastatic to the peritoneum including natural history and treatment options. They also preview future directions for the field.

In this episode of SurgOnc Today®, Carla Fisher, MD, Amy Degnim, MD and Faina Naklis, MD, discuss the management of high risk breast lesions including radial scars, papillomas without atypia, atypical ductal hyperplasia, atypical lobular hyperplasia and lobular carcinoma in situ.

Carla Fisher, MD, is a member of the SSO Breast DSWG and Director of Breast Surgery at Indiana University, Amy Degnim, MD, is the Joe M. and Ruth Roberts Professor of Surgery and Co-Leader of the Women’s Cancer Program at the Mayo Clinic and Faina Naklis, MD, is a surgeon at Brigham and Women’s / Dana-Farber.


In this episode of SurgOnc Today®, Vadim Gushchin, MD, Brian Badgwell, MD, and Jeremy Davis, MD discuss the role and timing of preoperative treatments before cytoreduction and HIPEC for gastric cancer. The panelists offer useful tips on surgical management of gastric cancer patients with peritoneal carcinomatoses, such as how to decide on the extent of the surgery, whether patients with CDH1 mutation should be treated differently, and others.


In this episode of SurgOnc Today®, Brian Badgwell, MD, Farshid Dayyani, MD, PhD, and Maheswari Senthil, MD, discuss the management of gastric cancer peritoneal carcinomatosis. Evaluation of response to systemic treatment, use of intraperitoneal chemotherapy and nuances of patient selection for Cytoreductive surgery are discussed.

In this episode of SurgOnc Today®, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.

In this episode, Melissa Hogg, MD, Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD, discuss the common and mostly benign imaging findings of the liver and biliary system with a focus on indications for surveillance, surgery, or additional necessary work-up.

The recently published EORTC 62092 trial (STRASS) examines abdominal recurrence in patients after surgical resection of retroperitoneal sarcomas.  This randomized study compared these recurrences in patients receiving neoadjuvant radiation versus those undergoing surgery alone.  Rebecca Gladdy MD, PhD and Ashleigh Guadagnolo, MD join moderator and SSO Sarcoma Disease Site Work Group Chair, Aimee Crago, MD, PhD, to provide insight and analysis from both surgical and radiation oncology perspectives, discussing how this practice-changing trial is altering the approach to patients with these diseases. 

In this episode of SurgOnc Today®, Kandace McGuire, MD, Chair of the SSO Breast Disease Site Work Group, moderates as Breast DSWG member Jennifer Plichta, MD, MS, presents practice changing studies from 2019.

In this episode of SurgOnc Today®, Alexander Parikh, MD, MPH, Vice Chair of the SSO Hepato-Pancreato-Biliary Disease Site Work Group moderates as Marcus Tan, MD, presents practice changing studies from 2019.

In this episode of SurgOnc Today®, Tina J. Hieken, MD, Vice Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Jessica Cintolo-Gonzalez, MD, and Kelly Olino, MD, present practice changing studies from 2019.

In this episode of SurgOnc Today®, Anthony Yang, MD, MS, Chair, and Carmen Solorzano, MD, Vice-Chair of the SSO Endocrine Disease Site Work Group, moderate as Linwah Yip, MD, from the Endocrine DSWG presents the following practice changing studies in endocrine surgical oncology from 2019.

In this episode of SurgOnc Today®, Lesly Dossett, MD, University of Michigan Hospital and Health Systems, and Member of the SSO Quality Committee interviews Daniel Boffa, MD from Yale University about hospital network affiliations and how they offer great potential for access to the right specialist at the right time.

“Part 1: Opioid Optimization in Surgical Oncology: Innovations in the Outpatient and Inpatient Settings”

In this episode of SurgOnc Today®, Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they discuss the important role that surgical oncologists play in post-operative opioid optimization. Learn about innovative ways being implemented in the outpatient and inpatient settings that are leading to safer, patient-centered, post-operative pain management.

Listen here.

“Part 2: Opioid Optimization in Surgical Oncology: Lessons Learned, Tips and Tricks, and Advancing Post-Operative Care”

Join moderator Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they resume their conversation on opioid optimization. These experts will discuss lessons learned in advancing post-operative pain management as well as practical tips on how to implement optimization pathways.Listen here.

In this episode of SurgOnc Today®, SSO Secretary, Kelly Hunt, MD interviews Mehra Golshan, MD, and Eleftherios (Terry) Mamounas, MD, about their involvement with the manuscript, “COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-Entry.” Dr. Golshan and Dr. Mamounas were appointed as SSO representatives to a consortium consisting of experts from The American Society of Breast Surgeons, the National Accreditation Program for Breast Centers, the National Comprehensive Cancer Network, the American College of Surgeons Commission on Cancer, the American College of Radiology and the American Society of Clinical Oncology.

In this episode of SurgOnc Today®, SSO President, James Howe, MD, interviews George Chang, MD, MD Anderson Cancer Center, about his experience being diagnosed with and recovering from COVID-19. Dr. Howe and Dr. Chang discussed symptoms, testing, hospitalization, returning to work and Dr. Chang’s experience donating his plasma to help give others passive immunity.

“The choice of neoadjuvant therapy for hormone receptor positive breast cancer”

In this episode of SurgOnc Today®, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma.

“Axillary management after neoadjuvant therapy in hormone receptor positive breast cancer”

In this episode of SurgOnc Today®, Armando Giuliano, MD, Tari King, MD and Melissa Pilewskie, MD, discuss the management of the axilla after preoperative systemic therapy. Evaluation of the axilla pre- and post chemotherapy along with surgical management is discussed in a case with a 3 cm, poorly differentiated invasive ductal carcinoma.

Navigate
Scroll to Top